1. Molecular epigenetic dynamics in breast carcinogenesis
   Aadrita Hazra et al, 2021, Archives of Pharmacal Research CrossRef
2. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
   Ruoning Yang et al, 2022, Molecular Biomedicine CrossRef
3. Triple-Negative Breast Cancer Treatment Advancements: A Review of Evolving Strategies
   Guozheng Liu et al, 2024, European Journal of Cancer Care CrossRef
4. Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature
   Yan Qin et al, 2021, Aging CrossRef
5. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer
   Yirivinti Hayagreeva Dinakar et al, 2023, AAPS PharmSciTech CrossRef
6. Synthesis, Characterization, and Assessment of Anti-Cancer Potential of ZnO Nanoparticles in an In Vitro Model of Breast Cancer
   Alaa A. A. Aljabali et al, 2022, Molecules CrossRef
7. Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks
   Aditya Lahiri et al, 2023, IEEE Access CrossRef
8. Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
   Mamta Kumari et al, 2020, Current Cancer Drug Targets CrossRef
9. Cell Cycle and Factors Involved in Inhibition or Progression of Breast Cancer
   Shazia Ali et al, 2020, Breast Cancer Biology CrossRef
10. Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway
    Shenghan Gao et al, 2023, Drug Design, Development and Therapy CrossRef